Kaisa Health expects H1 loss attributable to owners up to HK$65 millionPUBT·2 days ago, 07:05 AM00876+0.52%
Kaisa Health Group board to review interim results, consider dividendPUBT·Aug 13 at 06:09 AM00876+0.52%
Kaisa Health postpones special shareholder meeting to Sept. 1 from Aug. 18PUBT·Aug 12 at 06:29 AM00876+0.52%
Hong Kong's Fragmented Signals: From Property Defense to Tech Capital RaisingsGlobal Report·Aug 11 at 04:43 AM06098+0.54%02575-0.36%
Kaisa Health Group shifts Bermuda registered office to Richmond House from Aug. 3, 2026PUBT·Aug 7 at 09:59 AM00876+0.52%
Kaisa Health Plans Biotech-Focused Name Change After AcquisitionTip Ranks·Aug 6 at 10:11 AM00876+0.52%
Kaisa Health proposes renaming to Qinghai Biotech Pharmaceutical GroupPUBT·Aug 6 at 09:45 AM00876+0.52%
Kaisa Health proposes rebrand to Qinghai Pharmaceutical GroupPUBT·Jul 15 at 05:53 AM00876+0.52%029540.00%
Kaisa Health files board, board committee member list with disclosure responsibilitiesPUBT·Jul 13 at 09:36 AM00876+0.52%
